Journals / Akademik Araştırma Tıp Dergisi / 2017 / Cilt: 2 Sayı: 2

Primary Urethral Malignant Melanoma: Case Presentation

Primer Üretral Malign Melanom: Olgu Sunumu

Pages
59–61
Publication Date
2018-08-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Diagnosis and treatment are very important in these patients with high mortality rates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Primer urethral malignant melanoma is an extremely rare tumor.
📊
Key Findings & Data:It accounts for 2% of all malignmelanoma tumors and approximately 4% of urethral cancers.Case: We aimed to present an 84-year-old female patient without metastasis and non-recurrent urethral malignant melanoma.Conclusion: Approximately 150 cases have been reported in the literature.
💡
Conclusion & Impact:Diagnosis and treatment are very important in these patients with high mortality rates.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Primer · üretral · malign melanoma

Abstract

Introduction: Primer urethral malignant melanoma is an extremely rare tumor. It accounts for 2% of all malignmelanoma tumors and approximately 4% of urethral cancers.Case: We aimed to present an 84-year-old female patient without metastasis and non-recurrent urethral malignant melanoma.Conclusion: Approximately 150 cases have been reported in the literature. Tumors are difficult to diagnose and have a 5-year survival rate of around 10%. The risk factors for melanoma between the ages of 32 and 96 are not clearly explained. The TNM classification system, Clark level, Chung level and Breslow index for tumor staging will be useful.Urethral malignant melanoma is a rare tumor with poor prognosis. Diagnosis and treatment are very important in these patients with high mortality rates.

Özet

Amaç: Primer üretral malign melanom; son derece nadir görülen tümörlerdir. Tüm malign melanom tümörlerinin % 2’sini ve üretral kanserlerin de yaklaşık olarak %4’ünü oluşturmaktadır. Olgu: Olgumuzda; metastaz ve nüks olmayan üretral malign melanoma sahip 84 yaşında bayan hastayı sunmayı amaçladık. Tartışma: Literatürde yaklaşık 150 vaka bildirilmiş. Tanısı güç olan ve beş yıllık sağ kalım oranları %10 civarı olan tümörlerdir. Otuziki ile 96 yaşları arasında görülen melanom için risk faktörleri net açıklanamamıştır. Tümör evreleme için TNM sınıflama sistemi, Clark düzeyi, Chung düzeyi ve Breslow indeksi yararlı olacaktır.Üretral malign melanom kötü prognozlu nadir görülen tümörlerdendir. Yüksek mortalite oranlarına sahip bu hastalarda teşhis ve tedavi oldukça önemlidir.

🔖

Cite This Article

SARIKAYA, S., DAMAR, E., ÖZBEK, R., SELVİ, İ., ÇİFTÇİ, M., ŞİMŞEK, G. G., BOZKURT, Ö. F., ADSAN, Ö. (2018). Primary Urethral Malignant Melanoma: Case Presentation. Akademik Araştırma Tıp Dergisi, Cilt: 2 Sayı: 2, 59–61. https://ajindex.com/articles/981419

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Broussard AP, Chaudoir C, Gomelsky A. Urethral melanoma in an elderly woman. Int Urogynecol J. 2015;26:149-50
  2. Cho ST, Song HC, Cho B, Choi WS, Lee WK, Lee YS, et al. Primary malignant melanoma of the female urethra. Korean J Urol. 2012;53:206-8
  3. McComiskey M, Lavazzo C, Datta M, Slade R, Winter- Roach B, Lambe G, et al. Balloon cell urethral melanoma: Differential diagnosis and management. Case Rep Obstet Gynecol. 2015;91:9584
  4. Akbas A, Akman T, Erdem MR, Antar B, Kilicaslan I, Onol SY. Female urethral malignant melanoma with vesical invasion: A case report. Koashiung J Med Sci. 2010;26:96-8
  5. Ramos JA, Ramos WE, Ramos CV. Melanoma of the female urethra. Indian J Urol. 2011;27:448-450
  6. Papes D, Altarac S. Melanoma of the femal urethra. Med Oncol. 2013;30:329
  7. Pandey PK, Vijay MK, Goel H, Shukla S. Primary malignant melanoma of female urethra: A rare neoplasm. J Can Res Ther. 2014;10:758-60
  8. Kim CJ, Pak K, Hamaguchi A, Ishida A, Arai Y, Konishi T, et al. Primary malignant melanoma of the female urethra. Cancer. 1993;71:448-51.